David C. Mulligan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David C. Mulligan has a total of 393 co-authors. Here are the top co-authors by number of shared publications:
- John Peter Geibel
The John B. Pierce Laboratory, Inc., New Haven, CT 06519, USA
6 shared publications - Giorgio Caturegli
Yale School of Medicine, New Haven, CT, USA
4 shared publications - Manuel I. Rodriguez-Davalos
Liver Transplant Service, Intermountain Primary Children’s Hospital, Salt Lake City, UT
4 shared publications - Abedalrazaq Alkukhun
Division of Radiology, Department of Radiology, Yale School of Medicine, New Haven, CT
3 shared publications - Hugo E. Vargas
Mayo Clinic, Phoenix, Arizona, USA
3 shared publications - Jonathan Merola
Department of Surgery, Yale School of Medicine, NEW HAVEN, Connecticut, USA
3 shared publications
Latest Publications
- 8 July 2025
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 31 (12) , 1584-1586
CON: A multi-vendor organ procurement and transplantation network (OPTN) will not improve liver procurement and use
Export
- 8 July 2025
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 31 (12) , 1584-1586
CON: A multi-vendor organ procurement and transplantation network (OPTN) will not improve liver procurement and use
Export
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Transplantation
- Vol. 2025 (1)
A Rare Case of Cyberlindnera jadinii Fungemia in a Kidney Transplant Recipient: A Case Report
Despite revolutionary improvements in mortality, cardiovascular events, and quality of life, kidney transplantation has been plagued with perioperative mortality, graft rejection, and immunosuppression‐associated complications, most commonly infections. Fungal infections in particular only account for 5% of all cases but have the worst outcomes, with mortality ranging between 25% and 80% in solid organ transplant recipients. Candida , Cryptococcus , and Aspergillus species are the commonest causative agents, and isolated cases of other species have been reported in other immunosuppressed pathologies. Here, we present the first recorded case of Cyberlindnera jadinii fungemia in a kidney transplant recipient, highlighting the need for close surveillance, early diagnosis, and potentially continuing posttransplant antifungal prophylaxis beyond the current recommended duration.
- 1 January 2025
- Published by Wiley in Case Reports in Transplantation
- Vol. 2025 (1)
Open AccessA Rare Case of Cyberlindnera jadinii Fungemia in a Kidney Transplant Recipient: A Case Report
Despite revolutionary improvements in mortality, cardiovascular events, and quality of life, kidney transplantation has been plagued with perioperative mortality, graft rejection, and immunosuppression‐associated complications, most commonly infections. Fungal infections in particular only account for 5% of all cases but have the worst outcomes, with mortality ranging between 25% and 80% in solid organ transplant recipients. Candida , Cryptococcus , and Aspergillus species are the commonest causative agents, and isolated cases of other species have been reported in other immunosuppressed pathologies. Here, we present the first recorded case of Cyberlindnera jadinii fungemia in a kidney transplant recipient, highlighting the need for close surveillance, early diagnosis, and potentially continuing posttransplant antifungal prophylaxis beyond the current recommended duration.
- 9 September 2023
- Published by Elsevier in Surgical Clinics of North America
- Vol. 104 (1) , 1-9
Current Status of Liver Transplantation in North America
- 9 September 2023
- Published by Elsevier in Surgical Clinics of North America
- Vol. 104 (1) , 1-9
Current Status of Liver Transplantation in North America
- 30 August 2023
- Published by Wolters Kluwer Health in Transplantation
- Vol. 107 (11) , 2298-2301
New Allocation Systems: Principles and Processes (Pro)
- 30 August 2023
- Published by Wolters Kluwer Health in Transplantation
- Vol. 107 (11) , 2298-2301
New Allocation Systems: Principles and Processes (Pro)
- 16 March 2023
- Published by Wiley in Clinical Transplantation
- Vol. 37 (7) , e14954
Living donor liver transplant candidate and donor selection and engagement: Meeting report from the living donor liver transplant consensus conference
Introduction: Living donor liver transplantation (LDLT) is a promising option for mitigating the deceased donor organ shortage and reducing waitlist mortality. Despite excellent outcomes and data supporting expanding candidate indications for LDLT, broader uptake throughout the United States has yet to occur.Methods: In response to this, the American Society of Transplantation hosted a virtual consensus conference (October 18–19, 2021), bringing together relevant experts with the aim of identifying barriers to broader implementation and making recommendations regarding strategies to address these barriers. In this report, we summarize the findings relevant to the selection and engagement of both the LDLT candidate and living donor. Utilizing a modified Delphi approach, barrier and strategy statements were developed, refined, and voted on for overall barrier importance and potential impact and feasibility of the strategy to address said barrier.Results: Barriers identified fell into three general categories: 1) awareness, acceptance, and engagement across patients (potential candidates and donors), providers, and institutions, 2) data gaps and lack of standardization in candidate and donor selection, and 3) data gaps regarding post‐living liver donation outcomes and resource needs.Conclusions: Strategies to address barriers included efforts toward education and engagement across populations, rigorous and collaborative research, and institutional commitment and resources.
- 16 March 2023
- Published by Wiley in Clinical Transplantation
- Vol. 37 (7) , e14954
Living donor liver transplant candidate and donor selection and engagement: Meeting report from the living donor liver transplant consensus conference
Introduction: Living donor liver transplantation (LDLT) is a promising option for mitigating the deceased donor organ shortage and reducing waitlist mortality. Despite excellent outcomes and data supporting expanding candidate indications for LDLT, broader uptake throughout the United States has yet to occur.Methods: In response to this, the American Society of Transplantation hosted a virtual consensus conference (October 18–19, 2021), bringing together relevant experts with the aim of identifying barriers to broader implementation and making recommendations regarding strategies to address these barriers. In this report, we summarize the findings relevant to the selection and engagement of both the LDLT candidate and living donor. Utilizing a modified Delphi approach, barrier and strategy statements were developed, refined, and voted on for overall barrier importance and potential impact and feasibility of the strategy to address said barrier.Results: Barriers identified fell into three general categories: 1) awareness, acceptance, and engagement across patients (potential candidates and donors), providers, and institutions, 2) data gaps and lack of standardization in candidate and donor selection, and 3) data gaps regarding post‐living liver donation outcomes and resource needs.Conclusions: Strategies to address barriers included efforts toward education and engagement across populations, rigorous and collaborative research, and institutional commitment and resources.
- Open Access
- 7 January 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (2) , 165-170
Honoring the gift: The transformative potential of transplant-declined human organs
- 7 January 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (2) , 165-170
Open AccessHonoring the gift: The transformative potential of transplant-declined human organs
- 20 December 2021
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 28 (5) , 760-762
Clinical and Ethical Framework for Liver Retransplantation Using Living Donor Grafts: A Western Perspective
- 20 December 2021
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 28 (5) , 760-762
Clinical and Ethical Framework for Liver Retransplantation Using Living Donor Grafts: A Western Perspective
- Open Access
- 18 November 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (11) , e0260000
Inactive status is an independent predictor of liver transplant waitlist mortality and is associated with a transplant centers median meld at transplant
Approximately 30% of patients on the liver transplant waitlist experience at least one inactive status change which makes them temporarily ineligible to receive a deceased donor transplant. We hypothesized that inactive status would be associated with higher mortality which may differ on a transplant centers’ or donor service areas’ (DSA) Median MELD at Transplant (MMaT). Multi-state models were constructed (OPTN database;06/18/2013-06/08/2018) using DSA-level and transplant center-level data where MMaT were numerically ranked and categorized into tertiles. Hazards ratios were calculated between DSA and transplant center tertiles, stratified by MELD score, to determine differences in inactive to active transition probabilities. 7,625 (30.2% of sample registrants;25,216 total) experienced at least one inactive status change in the DSA-level cohort and 7,623 experienced at least one inactive status change in the transplant-center level cohort (30.2% of sample registrants;25,211 total). Inactive patients with MELD≤34 had a higher probability of becoming re-activated if they were waitlisted in a low or medium MMaT transplant center or DSA. Transplant rates were higher and lower re-activation probability was associated with higher mortality for the MELD 26–34 group in the high MMaT tertile. There were no significant differences in re-activation, transplant probability, or waitlist mortality for inactivated patients with MELD≥35 regardless of a DSA’s or center’s MMaT. This study shows that an inactive status change is independently associated with waitlist mortality. This association differs by a centers’ and a DSAs’ MMaT. Prioritization through care coordination to resolve issues of inactivity is fundamental to improving access.
- 18 November 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (11) , e0260000
Open AccessInactive status is an independent predictor of liver transplant waitlist mortality and is associated with a transplant centers median meld at transplant
Approximately 30% of patients on the liver transplant waitlist experience at least one inactive status change which makes them temporarily ineligible to receive a deceased donor transplant. We hypothesized that inactive status would be associated with higher mortality which may differ on a transplant centers’ or donor service areas’ (DSA) Median MELD at Transplant (MMaT). Multi-state models were constructed (OPTN database;06/18/2013-06/08/2018) using DSA-level and transplant center-level data where MMaT were numerically ranked and categorized into tertiles. Hazards ratios were calculated between DSA and transplant center tertiles, stratified by MELD score, to determine differences in inactive to active transition probabilities. 7,625 (30.2% of sample registrants;25,216 total) experienced at least one inactive status change in the DSA-level cohort and 7,623 experienced at least one inactive status change in the transplant-center level cohort (30.2% of sample registrants;25,211 total). Inactive patients with MELD≤34 had a higher probability of becoming re-activated if they were waitlisted in a low or medium MMaT transplant center or DSA. Transplant rates were higher and lower re-activation probability was associated with higher mortality for the MELD 26–34 group in the high MMaT tertile. There were no significant differences in re-activation, transplant probability, or waitlist mortality for inactivated patients with MELD≥35 regardless of a DSA’s or center’s MMaT. This study shows that an inactive status change is independently associated with waitlist mortality. This association differs by a centers’ and a DSAs’ MMaT. Prioritization through care coordination to resolve issues of inactivity is fundamental to improving access.
- Open Access
- 26 July 2021
- Published by Cambridge University Press (CUP) in Irish Journal of Psychological Medicine
- Vol. 38 (4) , 300
An approach to teaching psychiatry to medical students in the time of Covid-19 – Corrigendum
- 26 July 2021
- Published by Cambridge University Press (CUP) in Irish Journal of Psychological Medicine
- Vol. 38 (4) , 300
Open AccessAn approach to teaching psychiatry to medical students in the time of Covid-19 – Corrigendum
- Open Access
- 13 July 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (11) , 3593-3607
Developing simultaneous liver-kidney transplant medical eligibility criteria while providing a safety net: A 2-year review of the OPTN’s allocation policy
- 13 July 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (11) , 3593-3607
Open AccessDeveloping simultaneous liver-kidney transplant medical eligibility criteria while providing a safety net: A 2-year review of the OPTN’s allocation policy